ATS 2024 Final Program

Click on the session title to view the speakers

306

TUESDAY • MAY 21

1022 TBX4 Deletion in IPSC Results in Vascular Smooth Muscle Cells With Impaired Contractility, and Apoptosis Resistance That Induce EndoMT 1023 Single-cell Transcriptomics Analysis Reveals a Bidirectional Cross-talk Between Pulmonary Fibroblasts and Immune Cells in Distal Pulmonary Arteries of Hypoxia-exposed PH Calves 1024 Fructose Supports Erythrocyte Metabolism and Inhibits Erythrophagocytosis by Pulmonary Microvascular Endothelial Cells 1025 Perinatal Nicotine Exposure in Rats Leads to HFpEF, Pulmonary Hypertension, and Right Ventricular Hypertrophy Which Are Attenuated by a Potent PPAR? Agonist Rosiglitzaone

908 Genetic Support of the Causal Association Between Oral Microbiome on COVID-19: A Two-sample Mendelian Randomization Study 909 Pulmonary Surfactant Phospholipids Inhibit Replication of Several Types of Human Rhinovirus-C 910 Associations of COPD and Related Outcomes With COVID-19 Hospitalization or Death: The C4R, Copdgene, and Spiromics Studies 911 Post-acute Sequelae of COVID-19 Among Healthcare Workers: Findings From a National Registry 912 Endoplasmic Reticulum Stress Response Pathway Activation Patterns in Lung Fibrosis in End-stage IPF and COVID ARDS 913 Fate Determination of Neutrophils in Pulmonary Circulation in Severe Viral Pneumonia 914 Interactions of Chronic Recurrent Virus Infection/Vaccination With Long-term Low-dose PM2.5 Exposure: A Novel Mice Model 915 Investigation of ROS-induced Antiviral Effects in Epithelial Cells 916 Inhaled LNP-formulated siRNA Inhibits Human Parainfluenza Virus Type 3 Infection: From Bench to Bedside 917 Role of Tumor Necrosis Factor Superfamily Member 10 (TNFSF10) in SARS-CoV2-infection-associated Lung Damage 918 Effectiveness of the 23-valent Pneumococcal Polysaccharide Vaccine Against Community-acquired Pneumonia in Older Individuals After the Introduction of Childhood 13-valent Pneumococcal Conjugate Vaccine: A Multicenter Hospital-based Case-control Study in J 919 Are Sedative Medications a Modifiable Risk Factor for Non-ventilator Associated Hospital Acquired Pneumonia? 920 Aetiology of Aspiration Pneumonia in Adults Identified by Combined Detection Methods: A Multicenter Prospective Study 921 Pneumococcal Serotypes Distribution in Age Groups: New Factor for Worse Prognosis and an Opportunity for Prevention

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

C107 MICROBIAL RESPIRATORY INFECTIONS DISCOVERIES 2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 33A-C (Upper Level)

Poster Viewing

2:15-3:00

Discussion 3:00-4:15 901 Cystic Fibrosis Bacteriophage Study at Yale (CYPHY) 902 Rapid Diagnostics of Pleural Infections by Molecular Culture 903 Developing a Platform to Evaluate Mycobacterial Drug Resistance Through Inducible Knockdown and Complementation of Essential and Non-essential Genes 904 Differential Nutrient Availability During Acute Lung Injury Enhances Growth of Pseudomonas Aeruginosa 905 Mutations Drive Increased Elastase Activity in Pseudomonas Aeruginosa Clinical Isolates 906 Adaptation of Pseudomonas Aeruginosa During Colonization of Artificial Airways 907 Association of Pre-pandemic High Attenuation Areas on Lung CT and COVID-19 Hospitalization and Death: The C4R Study

ATS 2024 Conference Program • San Diego, CA